Valsts: Austrālija
Valoda: angļu
Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)
Tetrabenazine
_Consumer Medicine Information_ _Tetrabenazine_ TETRABENAZINE TABLETS CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Tetrabenazine Tablets. It does not contain all of the available information. Reading this leaflet does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of your taking Tetrabenazine Tablets against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING TETRABENAZINE TABLETS, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may want to read it again. WHAT TETRABENAZINE TABLETS ARE USED FOR Tetrabenazine is used for the treatment of diseases, which cause jerky, irregular, uncontrollable movements such as Huntington’s chorea, senile chorea and hemiballismus. Tetrabenazine affects some chemicals in the brain, and by doing so it helps to control jerky and irregular movements. Your doctor may have prescribed Tetrabenazine Tablets for another use. Ask your doctor if you have any questions about why Tetrabenazine Tablets have been prescribed for you. Tetrabenazine Tablets are not addictive. Tetrabenazine Tablets are only available on a doctor’s prescription. BEFORE YOU TAKE TETRABENAZINE TABLETS _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE TETRABENAZINE TABLETS IF: You are allergic to tetrabenazine or other ingredients of Tetrabenazine Tablets listed at the end of this leaflet. Tetrabenazine tablets contain lactose. It may cause problem in a small number of people who are sensitive to it. You are taking medicine containing reserpine. Izlasiet visu dokumentu
_Product Information _ _ _ _Tetrabenazine _ _Property of Valeant Pharmaceuticals Australasia Pty. Ltd. _ _Page 1 _ _Commercial-in_ PRODUCT INFORMATION TETRABENAZINE TABLETS NAME OF THE MEDICINE Tetrabenazine CAS Registry Number: 58 46 8 DESCRIPTION The chemical name of tetrabenazine is 1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2- methylpropyl)-2H-benzo-[a]quinolizin-2-one. Tetrabenazine is white to slightly yellow crystalline powder. Tetrabenazine is soluble in hot water, but practically insoluble in acetone. UV max (alcohol): 230, 284 nm ( 7780, 3820). Tetrabenazine Tablets contain tetrabenazine, lactose, starch, talc, magnesium stearate and iron oxide yellow. PHARMACOLOGY PHARMACODYNAMICS Tetrabenazine is a synthetic derivative of benzylquinolizine that causes depletion of dopamine and other monoamines in the central nervous system. Studies conducted _in vitro_ have shown that tetrabenazine is an inhibitor of monoamine transportation into pre-synaptic neuronal vesicles, by inhibition of VMAT2 (vesicular monamine transporter 2), which is principally located in the central nervous system. Dihydrotetrabenazine, the principal metabolite of tetrabenazine, has a similar affinity and more significant selectivity for VMAT2, and both compounds are believed to contribute to the pharmacological effect. _Product Information _ _ _ _Tetrabenazine _ _Property of Valeant Pharmaceuticals Australasia Pty. Ltd. _ _Page 2 _ _Commercial-in_ At a synaptic level tetrabenazine creates a reversible depletion of monamines in the presynaptic vesicles. Animal studies have shown that tetrabenazine cause Izlasiet visu dokumentu